Swiss HIV Cohort Study Group
Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017
Hampel B, Nguyen H, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard H, Braun D, Fehr J, Schmidt A, Nicca D, Kusejko K, Kouyos R, Böni J, Flepp M, Stöckle M, Conen A, Béguelin C, Künzler-Heule P, Swiss HIV Cohort Study Group. Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017. HIV Med 2019
Dec 18, 2019Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017
Dec 18, 2019HIV Med 2019
Hampel B, Nguyen H, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard H F, Braun D L, Fehr J, Schmidt A J, Nicca D, Kusejko K, Kouyos R D, Böni J, Flepp M, Stöckle M, Conen A, Béguelin C, Künzler-Heule Patrizia, Swiss HIV Cohort Study Group
Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians
Huber M, Weber R, Held L, Jaccard R, Bernasconi E, Nicca D, Orasch C, Calmy A, Battegay M, Cusini A, Fehr J, Young J, Sauter R, Ledergerber B, Swiss HIV Cohort Study Group. Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians. HIV Med 2012; 13:387-97.
Jan 18, 2012Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians
Jan 18, 2012HIV Med 2012; 13:387-97
Huber M, Weber R, Held L, Jaccard R, Bernasconi E, Nicca Dunja, Orasch C, Calmy A, Battegay M, Cusini A, Fehr J, Young J, Sauter R, Ledergerber B, Swiss HIV Cohort Study Group
Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians
Huber M, Weber R, Held L, Jaccard R, Bernasconi E, Nicca D, Orasch C, Calmy A, Battegay M, Cusini A, Fehr J, Young J, Sauter R, Ledergerber B, Swiss HIV Cohort Study Group. Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians. HIV medicine 2012; 13:387-397.
Jan 18, 2012Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians
Jan 18, 2012HIV medicine 2012; 13:387-397
Huber M, Weber R, Held L, Jaccard R, Bernasconi E, Nicca D, Orasch C, Calmy A, Battegay M, Cusini A, Fehr J, Young J, Sauter Rafael, Ledergerber B, Swiss HIV Cohort Study Group
Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study
Thierfelder C, Ledergerber B, Gutmann C, Bernasconi E, Calmy A, Cavassini M, Furrer H, Elzi L, Weber R, Swiss HIV Cohort Study Group. Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study. HIV Med 2011; 13:118-26.
Nov 22, 2011Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study
Nov 22, 2011HIV Med 2011; 13:118-26
Thierfelder C, Ledergerber B, Gutmann Christine, Bernasconi E, Calmy A, Cavassini M, Furrer H, Elzi L, Weber R, Swiss HIV Cohort Study Group
Predictive value of adherence in patients starting highly active antiretroviral treatment for HIV infection
Wagels T, Amiet R, Battegay M, Guex A, Opravil M, Vernazza P, Swiss HIV Cohort Study Group. Predictive value of adherence in patients starting highly active antiretroviral treatment for HIV infection. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2004; 134:678-80.
Nov 13, 2004Predictive value of adherence in patients starting highly active antiretroviral treatment for HIV infection
Nov 13, 2004Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2004; 134:678-80
Wagels T, Amiet R, Battegay M, Guex A C, Opravil M, Vernazza Pietro, Swiss HIV Cohort Study Group
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study
Young J, Bucher H, Battegay M, Vernazza P, Telenti A, Hirschel B, Bernasconi E, Furrer H, Rickenbach M, Flepp M, Spirig R, De Geest S, Swiss HIV Cohort Study Group. Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study. BMJ (Clinical research ed.) 2004; 328:15.
Jan 3, 2004Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study
Jan 3, 2004BMJ (Clinical research ed.) 2004; 328:15
Young Jim, Bucher Heiner C, Battegay Manuel, Vernazza Pietro, Telenti Amalio, Hirschel Bernard, Bernasconi Enos, Furrer Hansjakob, Rickenbach Martin, Flepp Markus, Spirig Rebecca, De Geest Sabina, Swiss HIV Cohort Study Group
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study
Kaufmann G, Battegay M, Egger M, Rickenbach M, Bernasconi E, Vernazza P, Ledergerber B, Hirschel B, Telenti A, Furrer H, Opravil M, Pantaleo G, Perrin L, Swiss HIV Cohort Study Group. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Archives of internal medicine 2003; 163:2187-95.
Oct 13, 2003CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study
Oct 13, 2003Archives of internal medicine 2003; 163:2187-95
Kaufmann Gilbert R, Battegay Manuel, Egger Matthias, Rickenbach Martin, Bernasconi Enos, Vernazza Pietro, Ledergerber Bruno, Hirschel Bernard, Telenti Amalio, Furrer Hansjakob, Opravil Milos, Pantaleo Guiseppe, Perrin Luc, Swiss HIV Cohort Study Group